Assessment of inflow of endotoxin and its fragments in patients on maintenance hemodialysis

Blood Purif. 2011;31(4):268-75. doi: 10.1159/000322622. Epub 2011 Jan 14.


Background: We estimated the flow of endotoxins (ET) from dialysates into the blood of patients on hemodialysis (HD) using limulus amebocyte lysate (LAL) assays and endotoxin activity (EA) determined by neutrophil respiratory burst activity.

Methods: A cross-sectional study compared groups given ultrapure bicarbonate (n = 15; group A), acetate-free bicarbonate dialysates (n = 20; group B) and conventional bicarbonate dialysate (n = 23; group C). A prospective study of group C examined the effect of changing the purity of the dialysate. Biomarkers of inflammation and oxidative stress were measured and ET in blood was assessed by LAL assays and EA.

Results: Serum ET levels did not differ among the groups, whereas EA and the biomarkers were significantly increased in group C compared with those in groups A and B. HD using conventional dialysate was independently associated with an increase in EA. Purifying the dialysate significantly decreased EA in group C.

Conclusion: Measuring EA is useful to assess the influence of dialysate contamination in HD patients.

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • Biomarkers / blood
  • Cross-Sectional Studies
  • Endotoxins / blood*
  • Endotoxins / metabolism
  • Female
  • Hemodialysis Solutions / chemistry
  • Hemodialysis Solutions / therapeutic use
  • Humans
  • Inflammation Mediators / blood
  • Kidney Failure, Chronic / blood
  • Kidney Failure, Chronic / metabolism
  • Kidney Failure, Chronic / therapy
  • Male
  • Middle Aged
  • Oxidative Stress
  • Renal Dialysis*
  • Risk Factors
  • Treatment Outcome


  • Biomarkers
  • Endotoxins
  • Hemodialysis Solutions
  • Inflammation Mediators